Metrovacesa stock
MVC.MCBMEMetrovacesa S.A., Real EstateISIN ES0105122024
52Score 52 out of 100, Neutral
Price and trend
61 / 100
Price history
+0.3% in one yearThe chart shows daily closes over 9 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 5.9% above it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 80).
The price is 12% below its 52-week high. Largest decline in 9 years: 71% (May 2018 to November 2020).
Chart figures for advanced users
- SMA 50$11.81
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$12.28
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)80
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$9.90
- The lowest closing price of the last twelve months.
- Resistance$14.74
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Metrovacesa S.A. belongs to the Real Estate (Development) industry (Spain) and, with a market value of $1.97B, is number 45 of 84 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $788.3M (up 8.4% year on year) and earnings of $63.27M (up 257.9%).
- MEQIRI Score 52 out of 100 (Neutral): rank 200 of 327 in Real Estate, median 55.
Show more
- The P/E is 31.1 (Real Estate (Development) median 11.4, own median of recent years 59.3).
- Our model puts fair value at $6.27, with the price 106% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 38.3% a year since 2020, Real Estate (Development) median 8.3%.Growth 70
- Earnings turn into cashFree cash flow 382% of earnings over the last 12 months.
Weaknesses
- Above fair valuePrice 106% above the fair value of $6.27.Valuation 21
- Dividend not coveredPayouts over the last 12 months were 542% of earnings and 110% of free cash flow.Capital allocation 25
- Dividend at riskDividend yield 17.4%. At yields this high (15% or more), the dividend was cut by at least a fifth within a year in 69 of 100 cases from 2011 to 2025, against 7 of 100 at 2 to 4%.Capital allocation 25
Its standout strengths are stability and growth, while capital allocation and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $4.82 and expensive above $8.95 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $7.78 (cash-flow model) and $4.75 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8%. At 9% the fair value would be $5.85, at 7% it would be $6.87.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (11.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue rose 8.4% on the prior year. Revenue has stayed largely stable since 2004.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 23%, operating 11%, net 8%.
Debt & balance sheet
latest quarterLow debt, and interest is adequately covered.
Earnings
- Next earnings
- 25 Feb 2027in 104 days
- Last reported
- 22 Jul 2026EPS reported $0.13 (expected $0.01)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $0.480.0%
- Revenue
- $829.79M0.0%
- Earnings per share
- $0.500.0%
- Revenue
- $869.2M0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Metrovacesa
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
327 rated companies in Real Estate
- This company
- 52
- Sector median
- 55
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Real Estate (Development)
The next larger and next smaller companies by market value
- CA Immobilien AnlagenCAI.VI $2.14B45
- Lumo KoditLUMO.HE $2.09B41
- Altarea SCAALTA.PA $2.04B38
- Neinor HomesHOME.MC $2.04B64
- ArganARG.PA $1.94B57
- InmocementoIMC.MC $1.88B71
- Intershop HoldingISN.SW $1.76B55
- Dom DevelopmentDOM.WA $1.61B73
ETFs that hold Metrovacesa
Held by 4 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Global X Superdividend UCITS ETF USDUDIV | 1.16% | 0.45% | €842.65M |
| WisdomTree Europe SmallCap Dividend UCITS ETFWTES | 0.55% | 0.38% | €86.74M |
| WisdomTree Europe Equity Income UCITS ETFWTEE | 0.15% | 0.29% | €241.09M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.